Introduction
============

Nanoparticles (NPs) have special physiochemical properties due to their small size, high reactivity, and large surface area. These properties lead to their extensive use in food and non-food industries, therapeutic processes, coating materials, consumer products, and fluorescent labels.[@b1-ijn-14-1919]--[@b3-ijn-14-1919]

Titanium dioxide nanoparticles (TiO~2~ NPs) are widely used in industries such as paper and also in plastics, paints, ceramics, cosmetics, water/air purifiers, agricultural chemicals, toothpastes, and sunscreens.[@b3-ijn-14-1919],[@b4-ijn-14-1919] They are also used in the food industry as whiteners in sauces and creamers.[@b5-ijn-14-1919] Due to the high use of this compound, the question arises whether TiO~2~ NPs can cause harm to basic tissues such as the intestine (the site of NP absorption) and the liver (the site of NP metabolism and detoxification). To the best of the authors' knowledge, few studies have reported the effects of TiO~2~ NPs on the intestine and liver as well as the mechanism of action.[@b6-ijn-14-1919]--[@b9-ijn-14-1919] Previous studies have shown that TiO~2~ NPs induce oxidative stress and inflammation in HepG2 and Caco-2 cells.[@b10-ijn-14-1919]--[@b12-ijn-14-1919] It has also been shown that TiO~2~ NPs increase ROS, inflammation, and apoptosis in the respiratory system.[@b13-ijn-14-1919] ROS attacks biomolecules such as DNA, proteins, lipids, and carbohydrates, which cause oxidation, methylation, deamination, apoptosis, and, consequently, lead to cell death.[@b14-ijn-14-1919] Azim et al[@b7-ijn-14-1919] showed that oral administration of TiO~2~ NPs (150 mg/kg/day) for 2 weeks in mice markedly elevated liver enzymes, malondialdehyde (MDA) levels, and gene expressions of *NF-κB* and Bax in hepatic tissue. TiO~2~ NPs (intraperitoneal \[i.p.\], 50 mg/kg for 30 days) also induced oxidative stress, DNA damage, and cell apoptosis in liver and kidney of rats.[@b15-ijn-14-1919] Furthermore, it has been reported that TiO~2~ NPs activate the inflammasome pathway and ultimately damage lung tissue.[@b13-ijn-14-1919] Inflammasome is a multiprotein complex that regulates inflammation by activating some cytokines such as IL-1β and IL-18.[@b16-ijn-14-1919] Activation of this pathway causes tissue damage and contributes to the development of intestinal and liver diseases.[@b16-ijn-14-1919],[@b17-ijn-14-1919] In this pathway, NLR family pyrin domain containing 3 (NLRP3) is the main component and activates caspase-1. The activation of this caspase causes pro-IL-1β to become active, which results in inflammation and tissue damage.[@b18-ijn-14-1919],[@b19-ijn-14-1919]

Jia et al[@b6-ijn-14-1919] showed that i.p. administration of TiO~2~ NPs (50--200 mg/kg) for 2 weeks exhibited toxicity in various tissues in mice. They showed that a low dose (5 mg/kg) of TiO~2~ NPs did not change antioxidant enzymes and MDA levels. Another study conducted on mice showed that administration of TiO~2~ NPs increased NLRP3 inflammasome, IL-18 and IL-1β levels and led to airway inflammation, proposing that TiO~2~ NPs initiate an innate immune response in the airway.[@b13-ijn-14-1919]

The intestine is an important organ of the body that interacts with the external environment and is directly related to external and toxic substances.[@b9-ijn-14-1919] In this respect, the small intestine is the major site for the absorption of metabolites and affects whole-body metabolism. The small intestine is exposed to NPs in several ways, which can probably lead to functional and structural changes.[@b9-ijn-14-1919] Engineered TiO~2~ NPs have become a commonly ingested material, and the influences of NPs on intestinal health function and structure are not well-recognized.[@b4-ijn-14-1919] On the other hand, the liver is a multicellular organ that plays a role in the activation and elimination of many metabolites.[@b20-ijn-14-1919] Studies have shown that the liver is the most important site for NP accumulation, which may be induced directly from intentional ingestion or indirectly through many food containers or secondary ingestion of inhaled NPs.[@b15-ijn-14-1919] Since both the intestine and the liver are directly related to harmful toxic substances, the aim of this experiment was to evaluate the effects of TiO~2~ NPs on oxidative stress, apoptosis, inflammation, and inflammasome pathways as well as the histopathology of these organs in rats. Furthermore, cytotoxicity, apoptosis rate, biochemical factors, and ROS production were studied in Caco-2 and HepG2 cells.

Materials and methods
=====================

Characterization of TiO~2~
--------------------------

TiO~2~ NP (rutile phase, 30 nm, and ≥99.9% trace metals basis) was obtained from Pishgaman Nanomaterial Company (Mashhad, Iran). The morphology and structure of TiO~2~ NP were measured using scanning electron microscopy (SEM, Supera 50 VP; Carl Zeiss Meditec AG, Jena, Germany), transmission electron microscopy (TEM, EM208; Philips, OR, USA), and X-ray diffraction (XRD, EQUINOX 3000; INEL, Artenay, France).

Cell culture, cytotoxicity assay, and biochemical factors
---------------------------------------------------------

The Caco-2 and HepG2 cell lines were purchased from the National Cell Bank of Pasteur Institute (Tehran, Iran) and cultured in DMEM with 10% (v/v) FBS at 37°C with 5% CO~2~

using a cell incubator. Cells were grown in standard situation until 80% confluent. After that, cells were treated with particle suspensions (5--300 µg/mL) for 24 hours (in 96-well culture plates).[@b21-ijn-14-1919] The MTT method was used to determine cell viability after TiO~2~ NP exposure based on the previously published paper.[@b22-ijn-14-1919] Caco-2 and HepG2 cells (in six-well culture plates) were lysed in the lysis buffer in order to measure glutathione (GSH) levels, and media were used for enzyme activity (n=3).[@b23-ijn-14-1919] Cytotoxicity induced by TiO~2~ NPs was also measured by lactate dehydrogenase (LDH) release, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) in medium using an automated analyzer (Hitachi Ltd., Tokyo, Japan).[@b24-ijn-14-1919] We determined the interference of TiO~2~ NP with ROS levels and LDH activity according to an earlier published paper.[@b25-ijn-14-1919] No interferences with ROS generation and LDH activity were reported at any concentration evaluated (data not shown), which show that the method was suitable for cytotoxicity measurement.

Intracellular ROS levels
------------------------

ROS levels in Caco-2 and HepG2 cells were determined by 2′,7′-dichlorofluorescin diacetate (DCFH-DA) based on the method of Shen et al.[@b26-ijn-14-1919] Fluorescence intensity was measured by a spectrofluorometer (FP-6200; Jasco, Portland, OR, USA) with excitation and emission wavelengths at 485 and 530 nm, respectively (n=3).[@b26-ijn-14-1919]

Cell apoptosis
--------------

The Caco-2 and HepG2 cells were treated with various concentrations of TiO~2~ NPs in six-well culture plates, and then single cell suspension was collected. Cells were washed in cold PBS, and the cell density was adjusted to 1×10^6^ cells/mL in PBS. Propidium iodide (PI) stock solution was added to each cell suspension and analyzed by flow cytometry (Attune NxT, Kansas, KS, USA) according to the previously published paper.[@b27-ijn-14-1919]

Animal ethics
-------------

Male Wistar rats (210 g, 8-week old) were procured from Hamadan University of Medical Sciences. They were kept in an animal house with relative humidity at 65%±5%, temperature at 22°C±2°C, and exposed to a 12-hour light/dark cycle. Standard diet and water were readily available. All experiments were approved and reviewed by the animal ethics committee of the Institutional Animal Care of Hamadan Medical University (Ethic code; IR.UMSHA.REC.1396.832, Hamadan, Iran). The experiments were performed in adherence to the guidelines for the Care and Use of Laboratory Animals of the National Institute of Health.

Animals and treatment
---------------------

Animals were allowed to adapt to the animal house for 1 week prior to experiments. After that, rats were randomly divided into four groups as follows (eight rats/group): 1) control rats (treated equally with sterile saline); 2) control rats that orally received 10 mg/kg TiO~2~ NPs; 3) control rats that orally received 50 mg/kg TiO~2~ NPs; and 4) control rats that orally received 100 mg/kg TiO~2~ NPs, once a day for 30 consecutive days. The intragastric doses of TiO~2~ NPs were chosen according to the study by Wang et al[@b28-ijn-14-1919] based on the intake of dietary TiO~2~ particles in human. After 30 days, all rats were weighed, anesthetized by ether, and then cervical dislocation was done. The blood was collected from heart of rats and intestine and liver tissues were removed to determine biochemical factors, gene expression, and histopathological analyses.

Biochemical tests
-----------------

The serum levels of ALT, AST, ALP, total bilirubin, LDH, blood urea nitrogen (BUN), and creatinine were determined using a commercially available kit by using an automated analyzer (Hitachi Ltd.).

Real-time PCR (RT-PCR)
----------------------

Following NP administration, the intestine and liver were processed for gene expression analysis. Total RNA was extracted using RNXplus reagent according to the manufacturer's instructions (CinnaGen, Tehran, Iran). RNA was reverse transcribed to cDNA using the Reverse Transcription Kit (Fermentas Life Sciences, Vilnius, Lithuania). RT-PCR was performed in a Real-Time PCR Detection System (Bio-Rad Laboratories Inc., Hercules, CA, USA). All reactions were performed in duplicate, and expressions of the various genes were normalized to the expression of glyceraldehyde-3-phosphate dehydrogenase (GADPH) and compared with the controls. The sequencing of primers was as follows: GAPDH (NM_017008.4) F: AAGGTCGGTGTGAACGGATTTGG, GAPDH R: TCCTGGAAGATGGTGATGGGTT; Bcl2 (NM_016993.1) F: TGTGGATGACTGAGTACCTGAACC, Bcl2 R: CAGCCAGGAGAAATCAAACAGAGG; Bax F (NM_017059.2): ACTAAAGTG CCCGAGCTGA, Bax R: ACTCCAGCCACAAAGATGGT; P53 (NM_030989.3) F: GTTCCGAGAGCTGAATGAGG, P53 R: TTTTATGGCGGGACGTAGAC; IL-1β (NM_031512.2) F: CCTTGTGCAAGTGTCTGAAG, IL-1β R: GGGCTTGGAAGCAATCCTTA; NLRP3 F (NM_001191642.1): AGAAGCTGGGGTTGGTGAATT, NLRP3 R: GTTGTCTAACTCCAGCATCTG; caspase (NM_012762.2) F: AGATGCCAACCACTGAAAGG, caspase R: GCATGATTCCCAACACAGGT; iNOS (NM_012611.3) F: AGAGACGCTTCTGAGGTTC, iNOS R: TTGATGCTTGTGACTCTTAGG; TNF-α (NM_012675.3) F: TGTTCATCCGTTCTCTACCCAC, TNF-α R: CACTACTTCAGCGTCTCGT; GPx (M_21210.1) F: GCTCACCCGCTCTTTACCTT, GPx R: AATGGACGAGAACATGCCCA; SOD (NM_017050.1) F: TCACTTCGAGCAGAAGGCAA, SOD R: CCTTTCCAGCAGCCACATTG; CAT (NM_012520.2) F: ATGGCT ATGGCTCACACACC, CAT R: GAGCACGGTAGGGAC AGTTC.[@b29-ijn-14-1919] The calculated formulae were as follows: ΔCt = target gene Ct -- GADPH Ct, ΔΔCt = test gene ΔCt -- control ΔCt, and gene expression = 2^−(ΔΔCt)^.

Antioxidant markers
-------------------

The activity of superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT) as well as GSH levels was determined in the treated animals using a commercially available kit (ZellBio, Ulm, Germany). Total oxidant status (TOS) was measured using xylenol orange, and total antioxidant capacity (TAC) was measured using the ferric ion reducing antioxidant potential (FRAP) method.[@b22-ijn-14-1919],[@b30-ijn-14-1919] The amount of MDA, a lipid peroxidation marker, was measured colorimetrically using thiobarbituric acid reactive substances (TBARS).[@b22-ijn-14-1919],[@b30-ijn-14-1919]

Analysis of apoptosis rates
---------------------------

Apoptosis rates in the intestine and liver were determined based on caspase-3 activity and TUNEL assay. To detect the apoptosis rate, a 4 µm paraffin section was prepared, and apoptosis rates in the intestine and liver were determined using the In Situ Cell Death Detection Kit (Hoffman-La Roche Ltd., Basel, Switzerland). The fluorescence-labeled images were visualized by fluorescence microscopy, and the number of TUNEL-positive cells, indicative of DNA damage, was quantified by Image-Pro software 6.0 (Silver Spring, MD, USA). The caspase-3 activity was determined using the fluorescence assay kit according to the manufacturer's protocols (Cayman Co., Ann Arbor, MI, USA).

IL-1β, tumor necrosis factor-α (TNF-α), and NO levels
-----------------------------------------------------

The IL-1β and TNF-α levels in the rat intestine and liver were determined using the ELISA kit according to the manufacturer's protocols (ZellBio, Ulm, Germany). The nitric oxide (NO) levels were determined according to the Griess reagent.[@b31-ijn-14-1919]

Histopathological changes
-------------------------

In histopathological analysis, intestine (the first part of jejemon) and liver (same lobe) tissues were dissected from rats and fixed in 10% formalin for 48 hours and embedded in paraffin. The intestine and liver sections were stained using Masson's trichrome (MT) and H&E. The percentage of hepatic pathological alterations was evaluated using Image-Pro Plus 6.0 (Silver Spring, MD, USA) under a light microscope (three sections/sample and six fields/slide) according to the Ishak system.[@b20-ijn-14-1919] The histopathological changes in intestine were determined according to the study by Erben et al.[@b32-ijn-14-1919]

Statistical analysis
--------------------

All data were expressed as mean ± SD. The statistical software SPSS (version 20.0; IBM Corporation, Armonk, NY, USA) was used to perform one-way ANOVA followed by Tukey's post hoc test. Significant difference was accepted at *P*\<0.05.

Results
=======

In vitro results
----------------

### Characterization of TiO~2~ NPs

TEM images showed that the TiO~2~ cluster suspension had an average diameter of 30 nm. In the characterization of NPs based on SEM and TEM images, TiO~2~ NPs showed a spherical shape with a size of about 30 nm. For the XRD pattern of the TiO~2~ NPs, strong diffraction peaks were revealed at 28°C, 36°C, and 54°C ([Figure S1](#SD1-ijn-14-1919){ref-type="supplementary-material"}), which were consistent with a standard spectrum of rutile TiO~2~ NPs. Based on the XRD results, the proportion of the rutile phase was 99.9%.

### Viability assay, biochemical factors, and ROS formation

Assessing cell viability is a vital step in toxicology that describes the cellular response to a toxin and gives evidence for survival, cell death, and metabolic activities.[@b33-ijn-14-1919] In the present experiment, cell viability was measured by evaluating the conversion of MTT to formazan. Results showed a dose-dependent reduction in cell viability for both the Caco-2 and the HepG2 cell lines after 24 hours exposure to TiO~2~ NPs ([Figure 1A](#f1-ijn-14-1919){ref-type="fig"}). The high concentrations of TiO~2~ NPs (100, 150, 200, and 300 µg/mL) also significantly increased the LDH activity in the Caco-2 and HepG2 cells after 24 hours ([Figure 1B and C](#f1-ijn-14-1919){ref-type="fig"}). TiO~2~ NPs caused a significant concentration-dependent increase in ALT and AST activity in HepG2 cells compared with untreated cells ([Figure 1C](#f1-ijn-14-1919){ref-type="fig"}). A significant decrease in intracellular GSH levels of Caco-2 ([Figure 1B](#f1-ijn-14-1919){ref-type="fig"}) and HepG2 cells ([Figure 1C](#f1-ijn-14-1919){ref-type="fig"}) was observed at 24 hours exposure of NPs (100, 150, 200, and 300 µg/mL).

The intracellular ROS formation was markedly elevated by TiO~2~ NPs in a dose-dependent manner. Caco-2 and HepG2 cells treated with TiO~2~ NPs (100--300 µg/mL) for 24 hours showed significant elevations in ROS levels ([Figure 1B and C](#f1-ijn-14-1919){ref-type="fig"}).

### Apoptosis rates in Caco-2 and HepG2 cells

Caco-2 and HepG2 cells treated with TiO~2~ NPs showed apoptosis induction as proved by the appearance of a major rise in the number of cells in the sub-G1 phase compared with the control cells. However, Caco-2 ([Figure 1B](#f1-ijn-14-1919){ref-type="fig"}) and HepG2 ([Figure 1C](#f1-ijn-14-1919){ref-type="fig"}) cells treated with 150, 200, and 300 µg/mL TiO~2~ NPs exhibited a noteworthy increase in the apoptosis rate compared with the control cells. Apoptosis rates at the concentrations \<150 mg/mL were not significant compared with control.

In vivo results
---------------

### Changes in biochemical parameters

[Table 1](#t1-ijn-14-1919){ref-type="table"} shows the biochemical factors in the serum of all treated groups. The activity of ALT, AST, LDH, and ALP as well as the total bilirubin, BUN, and creatinine levels was significantly increased in the TiO~2~ NP-treated groups when compared with the control rats after 30 days.

### Antioxidant gene expressions

The gene expressions of SOD, GPX, and CAT were significantly reduced in the 10, 50, and 100 mg/kg groups in a dose-dependent manner in the intestine ([Figure 2A](#f2-ijn-14-1919){ref-type="fig"}) and liver ([Figure 2B](#f2-ijn-14-1919){ref-type="fig"}).

### Effect of TiO~2~ NPs on the antioxidant system in rat

[Table 2](#t2-ijn-14-1919){ref-type="table"} shows antioxidant enzyme activities, antioxidant capacity, and lipid peroxidation in rats. The MDA and TOS concentrations were markedly increased, whereas TAC levels were reduced in the rats treated with 10, 50, and 100 mg/kg TiO~2~ NPs compared with those in the control group. The GSH levels were reduced in the three TiO~2~ NP-treated groups. The activity of GPX was markedly lower in the TiO~2~ NPs-treated groups (10, 50, and 100 mg/kg) compared with the control rat. The activity of CAT and SOD was significantly reduced in the liver of three TiO~2~ NP-treated groups compared with the control group. However, the reduction of CAT and SOD in the intestine of the 10 mg/kg TiO~2~ NPs group was not significant compared with the control rat.

### Apoptosis pathway gene expressions

The gene expressions of Bax and p53 were markedly elevated, and the Bcl-2 expression was reduced in the 10, 50, and 100 mg/kg groups (*P*\<0.001; [Figure 2A and B](#f2-ijn-14-1919){ref-type="fig"}). However, the change in the 100 mg/kg group was more significant. The cleaved caspase-3 activity was increased in the intestine and liver of three TiO~2~ NP-treated groups compared with the control rats ([Table 2](#t2-ijn-14-1919){ref-type="table"}).

### Number of TUNEL-positive cells in the intestine and liver

The number of TUNEL-positive cells was counted in the intestine and liver based on TUNEL and DAPI staining. In comparison with the control rat group, the mean number of TUNEL-positive cells per unit area in the intestine ([Figure 3A](#f3-ijn-14-1919){ref-type="fig"}) and the liver ([Figure 3B](#f3-ijn-14-1919){ref-type="fig"}) was significantly elevated in the TiO~2~ NP groups (*P*\<0.05). Significant increase in apoptotic cells was detected at the dose of 100 mg/kg compared with the control rats. Intestine and hepatic apoptosis rates were quantified by counting the number of apoptotic cells ([Figure 3C](#f3-ijn-14-1919){ref-type="fig"}).

### NLRP3 inflammasome pathway

The gene expressions of NLRP3 inflammasome, such as NLRP3, caspase-1, and IL-1β, were markedly increased in the 10, 50, and 100 mg/kg groups compared with the control rats (*P*\<0.05, [Figure 4A and B](#f4-ijn-14-1919){ref-type="fig"}). Furthermore, IL-1β levels were markedly increased in the 10, 50, and 100 mg/kg groups in comparison with the control rat (*P*\<0.001, [Figure 4C and D](#f4-ijn-14-1919){ref-type="fig"}).

### TNF-α and iNOS levels

Expression of the TNF-α and inducible nitric oxide synthase (*iNOS*) genes were strongly increased in TiO~2~ NP-treated rats in a dose-dependent manner (*P*\<0.001; [Figure 4A and B](#f4-ijn-14-1919){ref-type="fig"}). TiO~2~ NP also significantly increased TNF-α protein levels and NO levels in the intestine and liver of rats in a dose-dependent manner (*P*\<0.001; [Figure 4C and D](#f4-ijn-14-1919){ref-type="fig"}).

### Histopathological examination of intestine and liver tissues

Histopathological alterations of intestine and liver tissues were examined under light microscopy with H&E and MT staining ([Figures 5](#f5-ijn-14-1919){ref-type="fig"} and [6](#f6-ijn-14-1919){ref-type="fig"}).

Analysis of the small intestine revealed mononuclear cell infiltration, disruption, mucosal injury, disruption of crypt structure, necrosis, submucosal edema, erosion, as well as shedding and shortening of intestinal villi along with mucosal erosion in the TiO~2~ NP groups, but these alterations were not present in the control group. MT staining showed intestinal fibrosis in 50 and 100 mg/kg TiO~2~ NP groups ([Figure 5](#f5-ijn-14-1919){ref-type="fig"} and [Table 3](#t3-ijn-14-1919){ref-type="table"}).

H&E results showed liver cell degeneration, necrosis, congestion of the sinusoids, lymphocytic infiltration, and necrosis in the TiO~2~ NP groups in a dose-dependent manner. MT staining showed deposition of collagen in the TiO~2~ NP-treated groups ([Figure 6](#f6-ijn-14-1919){ref-type="fig"}; [Table 3](#t3-ijn-14-1919){ref-type="table"}). These results indicate that following TiO~2~ NP administration, histopathological changes were induced in the intestine and liver after 30 days.

Discussion
==========

It has been reported that, depending on one's dietary habits, children receive about 1--2 mg/kg and adults receive about 0.2--0.7 mg/kg of TiO~2~ NPs per day.[@b5-ijn-14-1919] According to the study by Wang et al,[@b28-ijn-14-1919] oral doses in rats were chosen based on the intake of dietary TiO~2~ NPs in the UK, which has been expected to be about 0.1 mg/kg/day. In their study, the 100 times dose of the potential human exposure (10 mg/kg) was used as the low-dose TiO~2~ NPs exposure in rats.[@b28-ijn-14-1919] Meena et al[@b15-ijn-14-1919] showed that treatment of rat with TiO~2~ NPs at the dose of 5 mg/kg did not induce oxidative stress in liver and kidney, whereas 50 mg/kg markedly elevated ROS levels in both the organs. According to the WHO report, median lethal dose (LD~50~) of TiO~2~ for rats is \>12 g/kg after oral consumption.[@b34-ijn-14-1919] In agreement with the experiments of Wang et al[@b28-ijn-14-1919] and Vasantharaja et al,[@b35-ijn-14-1919] we used TiO~2~ NPs at the doses of 10, 50, and 100 mg/kg.

The NP size has been defined \<100 nm. Automobile and diesel exhausts are the main sources of atmospheric NPs in urban areas.[@b13-ijn-14-1919] Most NPs from vehicle exhaust are in the size range 20--60 nm for gasoline engines and 20--130 nm for diesel engines. Weir et al[@b5-ijn-14-1919] showed that chewing gums, sweets, and candies contained the highest amount of TiO~2~ NPs in the scale of \<100 nm. NP absorption by the oral route rises with reducing particle diameter.[@b36-ijn-14-1919] Meena et al[@b15-ijn-14-1919] reported that TiO~2~ NPs with small distribution size (30--70 nm) can simply enter and localize inside cells. This can help in explanation of the oxidative stress observed. Furthermore, Guo et al[@b4-ijn-14-1919] reported that 30 nm TiO~2~ NP significantly altered nutrient transporter gene expression, ROS production, fatty acid and zinc absorption, ALP enzyme activity, and microvilli structure. In this study, TiO~2~ NPs showed the average diameter of 30 nm.

Based on the results from in vitro and in vivo experiments, it was found that TiO~2~ NP could cause oxidative stress, inflammation, apoptosis, and pathological changes in organs such as the intestine and the liver.[@b4-ijn-14-1919],[@b38-ijn-14-1919],[@b39-ijn-14-1919] In the present experiment, TiO~2~ NP induced toxicity, apoptosis, and increased ROS levels in HepG2 and Caco-2 cells. HepG2 cells are an appropriate in vitro model for the study of polarized human hepatocytes, as they secrete various key proteins that are vital for the study of cytotoxicity induced by NPs. Caco-2 is commonly used for drug absorption, apoptosis, and toxicity assessments.[@b33-ijn-14-1919] Hence, in this experiment, HepG2 and Caco-2 cells were selected for the assessment of target organ specificity. Hussain et al[@b40-ijn-14-1919] used the in vitro rat liver derived cell line (BRL 3A) and showed that exposure to TiO~2~ NPs (100--250 µg/mL) changes cellular morphology, increases LDH activity, ROS generation, and reduces GSH levels.

In this study, treatment of rats with TiO~2~ NP (especially at the dose of 50 and 100 mg/kg) induced oxidative damage in the intestine and liver. Changes in ROS, MDA levels (lipid peroxidation product), and antioxidant enzymes (SOD, CAT, and GPx) are sign of oxidative stress status.[@b14-ijn-14-1919],[@b37-ijn-14-1919],[@b41-ijn-14-1919] The current study showed that the antioxidant enzymes (CAT, GPx, and SOD) and non-enzyme levels (TAC and GSH) were markedly reduced and the TOS and MDA levels were increased in the intestine and liver of TiO~2~ NPs-treated groups. When ROS is increased, the body uses multiple antioxidant enzymes such as CAT, GPx, and SOD to clear ROS. SOD converts O~2~^−^ to H~2~O~2~ and O~2~, whereas GPx and CAT can eliminate H~2~O~2~ by converting it to water and O~2~. Therefore, CAT, GPx, and SOD keep ROS at a low concentration, effectively protecting the body from its toxic effects. However, high ROS production disrupts the balance of the oxidant/antioxidant system, causing lipid peroxidation and, consequently, liver and intestinal cell apoptosis.

The reduced CAT, GPx, and SOD activity and increased MDA and TOS concentration in the liver and the intestine indicate the oxidative stress induced by TiO~2~ NP. The results of Jia et al[@b6-ijn-14-1919] showed that i.p. administration of TiO~2~ NP to mice for 14 days led to mitochondrial damage and increased apoptotic bodies and ROS in the liver of mice. TiO~2~ NPs are recognized prooxidants that enter the cell by endocytosis and induce ROS generation, consequently, cause inflammation, apoptosis, and cell damage.[@b36-ijn-14-1919] On the other hand, when the mitochondria are invaded by the TiO~2~ NPs, the antioxidant enzymes (eg, SOD, CAT, and GPx) could be reduced.[@b42-ijn-14-1919]

The current results showed that TiO~2~ NPs increased pro-apoptotic factors (BAX, caspase-3, and P53) and decreased anti-apoptotic factor (Bcl-2) in the intestine and the liver. In this experiment, the TUNEL assay also proved apoptosis in these organs. Furthermore, the activity of caspase-3 significantly increased in TiO~2~ NP-treated groups. The current findings are supported by other previous reports that have shown that TiO~2~ NPs increased liver apoptosis through the activation of apoptotic gene expression.[@b3-ijn-14-1919],[@b39-ijn-14-1919] The results of Shukla et al showed that TiO~2~ NPs induced oxidative DNA damage and apoptosis in HepG2 cells.[@b3-ijn-14-1919] Furthermore, Park et al showed that TiO~2~ NPs induced ROS production and apoptosis in cultured BEAS-2B cells.[@b11-ijn-14-1919]

The caspases and Bcl-2 family of proteins (antiapoptotic and pro-apoptotic proteins) are recognized as the main regulators of the apoptotic pathway.[@b43-ijn-14-1919] Bax translocation into mitochondria could change the cytochrome C permeability, followed by stimulation of the post-mitochondrial caspase, leading to apoptotic cell death.[@b43-ijn-14-1919] Bcl-2 prevents cell apoptosis by decreasing the release of cytochrome C in order to suppress caspase-3 activation.[@b44-ijn-14-1919] Intrinsic and extrinsic pathways are two main routes of apoptosis.[@b44-ijn-14-1919] In the intrinsic pathway, various members of the Bcl-2 protein family elevate pro-apoptotic factors and mitochondrial permeability. Then, cytochrome C is released into the cytosol and that consequently leads to the activation of caspase-3.[@b44-ijn-14-1919] Previous studies have reported that NPs can induce cellular apoptosis by targeting the mitochondrial apoptotic pathway by stimulating cytochrome C release from the mitochondria, declining Bcl-2 expression, the overexpression of Bax, and by increasing caspase-3 activity.[@b8-ijn-14-1919]

It has been demonstrated that caspase-3 is a major effector in the apoptosis process and that its activation marks the irreversible stage of this pathway.[@b43-ijn-14-1919] Caspase-3 is stimulated in the apoptotic cell both by intrinsic (mitochondrial) and extrinsic (death ligand) pathways.[@b44-ijn-14-1919] It has been shown that TiO~2~ NPs induced apoptosis in animal models by activating caspase-3.[@b45-ijn-14-1919] Shukla et al[@b3-ijn-14-1919] reported that administration of TiO~2~ NPs (100 mg/kg) to mice for 14 consecutive days led to pathological damage to the liver, such as increased oxidative stress, DNA damage, augmented proapoptotic factors (BAX, caspase-3 and -9, and p53), and a reduction in the anti-apoptotic factor (Bcl-2). These results indicate that TiO~2~ NPs can induce cell apoptosis through the caspase-dependent signaling pathway. TiO~2~ NPs can also lead to chromatin condensation, nuclear fragmentation, and, consequently, induce apoptosis.[@b46-ijn-14-1919] Previous studies have reported that TiO~2~ NPs lead to mutation in the p53 gene and other genes regulating apoptosis, thus altering their expression and, consequently, producing genotoxic effects.[@b1-ijn-14-1919] The intrinsic mitochondria apoptosis pathway has a main role in NP-induced cell death since mitochondria is one of the key target organelles for NP-induced oxidative stress. High ROS generation in the mitochondria can lead to damage to membrane phospholipids inducing mitochondrial membrane depolarization and, consequently, inducing apoptosis.[@b47-ijn-14-1919]

It has been proposed that ROS contribute to inflammasome activation.[@b17-ijn-14-1919] The current data demonstrate that the administration of TiO~2~ NP significantly activated the NLRP3 inflammasome pathway in the intestine and liver. Inflammasomes are main contributors to inflammation, which can sense both exogenous and endogenous danger signals via intracellular nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs).[@b19-ijn-14-1919] Activation of NLRP3 inflammasome is involved in the pathogenesis of chronic inflammation-related disorders, such as chronic liver disease (CLD).[@b19-ijn-14-1919] Furthermore, another experiment reported that NLRP3 inflammasome can contribute to liver failure as well as in the development of non-alcoholic steatohepatitis (NASH) in animal models.[@b19-ijn-14-1919] It was observed that NLRP3 activation led to hepatocyte pyroptosis, severe liver inflammation, and hepatic stellate cell (HSC) activation with collagen deposition.[@b48-ijn-14-1919] Of note, the MT analysis in the current study showed that collagen deposition was significantly increased in the TiO~2~ NP-treated groups.

It has been documented that inflammasome is a vital regulator of gastrointestinal homeostasis and is a key factor influencing the development of intestinal inflammation through caspase-1 cleavage and the downstream production of IL-1β.[@b16-ijn-14-1919] IL-1β is a strong pro-inflammatory cytokine exerting a plethora of local and systemic effects. IL-1β stimulates the recruitment of immune cells to the inflammation site by inducing chemoattractants and adhesion molecules. IL-1β stimulates the activation and effector functions of macrophages, neutrophils, and dendritic cells.[@b49-ijn-14-1919] In the intestine, it appears that lamina propria phagocytes contain the major source of IL-1β during gastrointestinal inflammation.[@b49-ijn-14-1919] It has been documented that IL-1β signaling has a principal role in mediating intestinal inflammation.[@b49-ijn-14-1919] Abnormal activation of NLRP3 inflammasome has also been incriminated in the pathogenesis of intestinal disorders such as inflammatory bowel diseases (IBD).[@b16-ijn-14-1919] Another study showed that treatment with TiO~2~ NPs significantly induced the NLRP3 inflammasome pathway in lung.[@b13-ijn-14-1919] It has been reported that TiO~2~ NPs induce NLRP3-ASC-caspase-1 assembly and caspase-1 cleavage, leading to IL-1β release.[@b50-ijn-14-1919] TiO~2~ NPs can deposit inside the subcellular organelles or on the cellular surface and induce oxidative stress signaling cascades that finally lead to oxidative damage, inflammatory response, and apoptosis.[@b47-ijn-14-1919] In this study, TiO~2~ NPs also induced inflammatory responses in liver and intestine by increasing TNF-α and iNOS levels in a dose-dependent manner. This is in accordance with the previous experiment that showed that TiO~2~ NPs increased cytokine levels in rat.[@b36-ijn-14-1919] TNF-α is a potent pro-inflammatory cytokine associated with intestinal dysfunction and liver injury.[@b51-ijn-14-1919] On the other hand, iNOS in pathological situation produces high levels of NO, which is a main source of reactive nitrogen species (RNS). Peroxynitrite (ONOO^−^) is a main RNS, which can damage lipids, proteins, and DNA and consequently lead to liver and intestinal injury.[@b52-ijn-14-1919]

We showed that exposure to TiO~2~ NPs led to several alterations in the cellular architecture of rat intestine and liver tissues relative to the healthy rats. The cellular degeneration induced by TiO~2~ NPs is a line of evidence supporting the potential of the NPs to cause biochemical changes and oxidative stress leading to cellular damage. In this experiment, high doses of TiO~2~ NPs markedly elevated the serum levels of ALT, AST, LDH, ALP, total bilirubin, creatinine, and BUN, which are indices for liver and kidney function. When the hepatic membrane and cells are injured or died, the amount of ALT, AST, LDH, and ALP elevates in the plasma, and this increase in amount is a sign of liver damage.[@b35-ijn-14-1919] Vasantharaja et al[@b35-ijn-14-1919] showed that administration of TiO~2~ NPs in rats (50 mg/kg, for 2 weeks) led to liver damage and increased hepatic marker enzymes. Previous experiments have reported the potential of NPs to sequester in tissues and thus cause cellular injury.[@b2-ijn-14-1919] Our findings indicated that administration of TiO~2~ NPs led to histological changes in the liver, including irregular structure of hepatocyte cells, necrosis, apoptosis features, portal inflammation, degeneration, and congestion of the sinusoids. A significant reduction in hepatocytes count per unit area was detected in TiO~2~ NP-treated rats. In agreement with our results, Alarifi et al[@b39-ijn-14-1919] reported that 24-hour exposure of rats to TiO~2~ NPs (252 mg per animal, i.p.) led to liver histopathological changes including cloudy swelling, congested dilated central veins, hydropic degeneration, fatty degeneration, and infiltration of inflammatory cells. The presence of inflammatory cells in liver tissue proposes that the TiO~2~ NPs can interact with enzymes and proteins in the interstitial tissue of the liver, interfering with the antioxidant defense mechanism and causing ROS production, which in turn may imitate inflammation and histopathological alterations.[@b39-ijn-14-1919] Furthermore, administration of TiO~2~ NPs led to histological changes in the intestine, including cell infiltration, edema, mucosal disruption, erosion, and injury, as well as shortening and shedding of intestinal villi. In agreement with the current findings, Tassinaria et al[@b53-ijn-14-1919] showed that oral administration of TiO~2~ NPs (2 mg/kg for 5 days) in rats can alter villous dimensions. These findings identify NLRP3 inflammasome, inflammation, oxidative stress, and apoptosis induced intestine and liver injury after exposure to TiO~2~ NPs.

Conclusion
==========

The results of this study showed that the administration of TiO~2~ NPs in a dose-dependent manner induces hepatic and intestinal oxidative stress, inflammation, and apoptosis, which was strongly accompanied by histopathological changes in intestine and liver. Further experiments are still required to determine the mechanism of harmful effects of TiO~2~ NP in various cell lines and other animal species. Furthermore, comprehensive experiments are needed to determine whether low TiO~2~ NP doses for a long period can induce toxicity in the liver, particularly in the presence of therapeutic agents.
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###### 

Characterization of TiO~2~ NPs.

**Note:** SEM (**A**), TEM image (**B** and **C**), and XRD pattern (**D**) of TiO~2~ NPs.

**Abbreviations:** SEM, scanning electron microscopy; TEM, transmission electron microscopy; TiO~2~ NPs, titanium dioxide nanoparticles; XRD, X-ray diffraction.
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![The in vitro studies of TiO~2~ NPs.\
**Notes:** Effect of TiO~2~ NPs on cell viability (**A**), enzyme activity, ROS generation, GSH levels, and apoptosis rate in Caco-2 cells (**B**) and HepG2 cells (**C**) after 24 hours (n=3). Values were expressed as mean ± SD. ^\*^*P*\<0.05, ^\#^*P*\<0.01, and ^Ŧ^*P*\<0.001 as compared to control. Apoptosis rates at the concentrations \<150 µg/mL TiO~2~ NPs were not significant compared to control.\
**Abbreviations:** ALT, alanine aminotransferase; AST, aspartate aminotransferase; GSH, glutathione; LDH, lactate dehydrogenase; TiO~2~ NPs, titanium dioxide nanoparticles.](ijn-14-1919Fig1){#f1-ijn-14-1919}

![Effect of TiO~2~ NPs on antioxidant gene expressions and apoptosis pathway.\
**Notes:** Treatment of rats with TiO~2~ NPs significantly reduced antioxidant gene expressions and induced apoptosis pathway in the intestine (**A**) and liver (**B**) of different treated groups. Values were expressed as mean ± SD. ^\*^*P*\<0.05, ^\#^*P*\<0.01, and ^Ŧ^*P*\<0.001 as compared to the control group. ^£^*P*\<0.05 as compared to the "Control +10 mg/kg NPs" group and ^§^*P*\<0.05 as compared to the "Control +50 mg/kg NPs" group.\
**Abbreviations:** CAT, catalase; GPx, glutathione peroxidase; SOD, superoxide dismutase; TiO~2~ NPs, titanium dioxide nanoparticles.](ijn-14-1919Fig2){#f2-ijn-14-1919}

###### 

Apoptosis determined in the intestine and liver by TUNEL.

**Notes:** Analysis of apoptosis by TUNEL staining of intestine (**A**) and liver (**B**) compared to control rats (magnification, 400×). Counter staining was done using DAPI nuclear staining, and pictures were taken using DAPI (**i**), fluorescein isothiocyanate (apoptotic cells; **ii**), and merged (**iii**) filters. Intestine and liver apoptosis were quantified by counting the number of apoptotic cells (**C**). Values were expressed as mean ± SD. ^\*^*P*\<0.05, and ^Ŧ^*P*\<0.001 as compared to the control group. ^£^*P*\<0.05 as compared to the "Control +10 mg/kg NPs" group and ^§^*P*\<0.05 as compared to the "Control +50 mg/kg NPs".

**Abbreviation:** TiO~2~ NPs, titanium dioxide nanoparticles.

![](ijn-14-1919Fig3)

![](ijn-14-1919Fig3a)

###### 

Effect of TiO~2~ NPs on inflammasome and inflammatory pathways.

**Notes:** Treatment of rats with TiO~2~ NPs significantly increased inflammasome and inflammatory gene expressions in the intestine (**A**) and liver (**B**), and the IL-1β protein, TNF-α protein, and nitric oxide levels in the intestine (**C**) and liver (**D**). Values were expressed as mean ± SD. ^\*^*P*\<0.05, ^\#^*P*\<0.01, and ^Ŧ^*P*\<0.001 as compared to the control group. ^£^*P*\<0.05 as compared to the "Control +10 mg/kg NPs" group and ^§^*P*\<0.05 as compared to the "Control +50 mg/kg NPs".

**Abbreviations:** iNOS, inducible nitric oxide synthase; NLRP3, NLR family pyrin domain containing 3; TiO~2~ NPs, titanium dioxide nanoparticles; TNF-α, tumor necrosis factor-α.

![](ijn-14-1919Fig4)

![](ijn-14-1919Fig4a)

![Morphological alteration of intestine.\
**Notes:** Effects of TiO~2~ NPs on histological changes of intestine determined by H&E (**A**), and MT staining (**B**) (magnification, 400×). Results showed that in TiO~2~ NP-treated groups crypt structure is injured and mucosa is eroded. Moreover, edema, necrosis, disruption, shortening, and loosening of intestinal villi are present. Arrow indicates collagen deposition and straight line shows villi altitude.\
**Abbreviations:** MT, Masson's trichrome; TiO~2~ NPs, titanium dioxide nanoparticles; H&E, Hematoxylin and Eosin.](ijn-14-1919Fig5){#f5-ijn-14-1919}

![Morphological alteration of liver.\
**Notes:** Effects of TiO~2~ NPs on histological changes of liver determined by H&E (**A**) and MT staining (**B**) (magnification, 400×). Arrow indicates collagen deposition and straight line shows central vein diameter.\
**Abbreviations:** MT, Masson's trichrome; TiO~2~ NPs, titanium dioxide nanoparticles; H&E, Hematoxylin and Eosin.](ijn-14-1919Fig6){#f6-ijn-14-1919}

###### 

Comparison of biochemical factors in the serum of different treated animals

  Groups                    Control        Control +10 mg/kg NPs                                     Control +50 mg/kg NPs                                                                                  Control +100 mg/kg NPs
  ------------------------- -------------- --------------------------------------------------------- ------------------------------------------------------------------------------------------------------ -----------------------------------------------------------------------------------------------------
  ALT (U/L)                 43.80±6.34     63.80±4.86[\*](#tfn2-ijn-14-1919){ref-type="table-fn"}    81.80±6.83[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[£](#tfn5-ijn-14-1919){ref-type="table-fn"}      106.60±8.67[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[§](#tfn6-ijn-14-1919){ref-type="table-fn"}
  AST (U/L)                 57.40±7.56     85.00±12.66[\*](#tfn2-ijn-14-1919){ref-type="table-fn"}   100.20±6.94[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"}                                                 126.40±7.05[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[§](#tfn6-ijn-14-1919){ref-type="table-fn"}
  LDH (U/L)                 402.80±8.31    422.20±15.56                                              519.00±22.54[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[£](#tfn5-ijn-14-1919){ref-type="table-fn"}    767.60±33.90[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[§](#tfn6-ijn-14-1919){ref-type="table-fn"}
  ALP (U/L)                 134.80±17.88   155.20±14.30                                              178.60±11.14[\#](#tfn3-ijn-14-1919){ref-type="table-fn"},[£](#tfn5-ijn-14-1919){ref-type="table-fn"}   271.40±12.11[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[§](#tfn6-ijn-14-1919){ref-type="table-fn"}
  Total bilirubin (mg/dL)   2.00±0.23      2.84±0.33[\*](#tfn2-ijn-14-1919){ref-type="table-fn"}     3.02±0.31[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"}                                                   3.28±0.33[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[§](#tfn6-ijn-14-1919){ref-type="table-fn"}
  BUN (mg/dL)               18.0±3.0       21.00±2.50                                                43.00±4.40[\#](#tfn3-ijn-14-1919){ref-type="table-fn"},[£](#tfn5-ijn-14-1919){ref-type="table-fn"}     55.0±4.0[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[§](#tfn6-ijn-14-1919){ref-type="table-fn"}
  Creatinine (mg/dL)        0.60±0.1       0.9±0.05                                                  1.8±0.02[\#](#tfn3-ijn-14-1919){ref-type="table-fn"},[£](#tfn5-ijn-14-1919){ref-type="table-fn"}       2.10±0.10[Ŧ](#tfn4-ijn-14-1919){ref-type="table-fn"},[§](#tfn6-ijn-14-1919){ref-type="table-fn"}

**Notes:** Data were expressed as mean ± SD.

*P*\<0.05,

*P*\<0.01, and

*P*\<0.001 compared with the control group.

*P*\<0.05 as compared to the "Control +10 mg/kg NPs" group and

*P*\<0.05 as compared to the "Control +50 mg/kg NPs".

**Abbreviations:** AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen; LDH, lactate dehydrogenase; NPs, nanoparticles.

###### 

Effects of TiO~2~ NPs on antioxidant enzyme activities, antioxidant capacity, lipid peroxidation, and caspase activity in the liver and intestine of different treated animals

  Variables                             Control group   Control +10 mg/kg NPs group   Control +50 mg/kg NPs group                              Control +100 mg/kg NPs group                                                                                                                                                                                                                                                                                                                                             
  ------------------------------------- --------------- ----------------------------- -------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------
  SOD (unit/mg pr)                      99.2±7.1        87.0±8.3                      81.0±9.1[\#](#tfn10-ijn-14-1919){ref-type="table-fn"}    72.8±8.0                                                 59.80±6.1[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}   59.0±13.5[\#](#tfn10-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}   35.0±3.5[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}    32.4±1.6[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}
  CAT (unit/mg pr)                      57.0±5.3        51.6±5.9                      45.20±7.6[\*](#tfn9-ijn-14-1919){ref-type="table-fn"}    42.6±6.0                                                 33.40±4.5[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}   32.8±6.4[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}     22.4±1.8[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}    21.0±2.7[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}
  GPx (unit/mg pr)                      60.2±7.1        54.8±4.6                      38.2±11.9[\#](#tfn10-ijn-14-1919){ref-type="table-fn"}   39.2±5.2[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}     36.20±3.8[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}                                                35.2±5.26[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}                                                 19.8±2.1[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}    16.6±1.8[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}
  GSH (µg/mg pr)                        130.2±7.4       148.4±14.7                    105.60±4.7[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}   116.8±5.0[\#](#tfn10-ijn-14-1919){ref-type="table-fn"}   72.60±8.9[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}   111.8±3.0[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}                                                 52.4±4.9[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}    44.8±7.0[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}
  MDA (nmol/mg pr)                      12.4±1.3        9.0±1.4                       22.80±5.7[\#](#tfn10-ijn-14-1919){ref-type="table-fn"}   18.9±1.0[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}     28.1±2.9[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}                                                 24.5±3.6[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}     38.7±2.9[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}    34.8±3.0[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}
  TAC (nmol/mg pr)                      83.6±3.5        72.4±10.8                     56.80±9.1[\#](#tfn10-ijn-14-1919){ref-type="table-fn"}   49.20±6.2[\#](#tfn10-ijn-14-1919){ref-type="table-fn"}   31.2±4.6[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}    33.0±6.2[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}     22.4±2.7[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}    17.8±2.38[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}
  TOS (nmol/mg pr)                      7.4±0.8         7.9±0.8                       11.04±1.2[\#](#tfn10-ijn-14-1919){ref-type="table-fn"}   14.6±0.9[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}     15.3±1.6[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}                                                 18.3±2.8[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"}                                                  22.7±1.8[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}    23.1±1.6[Ŧ](#tfn11-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}
  Caspase-3 activity (arbitrary unit)   10±0.0          10±0.0                        13.6±0.6[\*](#tfn9-ijn-14-1919){ref-type="table-fn"}     13.8±0.5[\*](#tfn9-ijn-14-1919){ref-type="table-fn"}     15.5±0.2[\#](#tfn10-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}   14.8±0.3[\#](#tfn10-ijn-14-1919){ref-type="table-fn"},[£](#tfn12-ijn-14-1919){ref-type="table-fn"}    16.9±0.5[\#](#tfn10-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}   17.0±0.5[\#](#tfn10-ijn-14-1919){ref-type="table-fn"},[§](#tfn13-ijn-14-1919){ref-type="table-fn"}

**Notes:** TiO~2~ NPs significantly increased SOD, CAT, and GPX activity as well as GSH and TAC levels in rats, whereas TiO~2~ NPs reduced TOS and MDA levels in the intestine and liver. Values were expressed as mean ± SD.

*P*\<0.05,

*P*\<0.01, and

*P*\<0.001 as compared to the control group.

*P*\<0.05 as compared to the "Control +10 mg/kg NPs" group and

*P*\<0.05 as compared to the "Control +50 mg/kg NPs".

**Abbreviations:** CAT, catalase; GSH, glutathione; GPx, glutathione peroxidase; MDA, malondialdehyde; pr, protein; SOD, superoxide dismutase; TAC, total antioxidant capacity; TiO~2~ NPs, titanium dioxide nanoparticles; TOS, total oxidant status.

###### 

Intestinal and liver histopathological changes in different treated animals

  Tissues                                       Pathological assessment   Control                                              Control + 10 mg/kg NPs                                                                            Control + 50 mg/kg NPs                                                                            Control + 100 mg/kg NPs
  --------------------------------------------- ------------------------- ---------------------------------------------------- ------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------- -------------------------
  Intestine                                     Cell infiltration         0                                                    1                                                                                                 1                                                                                                 2
  Mucosal disruption and injury                 0                         1                                                    2                                                                                                 2                                                                                                 
  Shortening and shedding of intestinal villi   0                         1                                                    2                                                                                                 3                                                                                                 
  Mucosal erosion                               0                         1                                                    2                                                                                                 2                                                                                                 
  Edema                                         0                         1                                                    2                                                                                                 2                                                                                                 
  **Total grade**                               **0**                     **5**[\*](#tfn16-ijn-14-1919){ref-type="table-fn"}   **9**[Ŧ](#tfn17-ijn-14-1919){ref-type="table-fn"},[£](#tfn18-ijn-14-1919){ref-type="table-fn"}    **11**[Ŧ](#tfn17-ijn-14-1919){ref-type="table-fn"},[§](#tfn19-ijn-14-1919){ref-type="table-fn"}   
  Liver                                         Confluent necrosis        0                                                    0                                                                                                 1                                                                                                 2
  Focal necrosis                                0                         2                                                    2                                                                                                 3                                                                                                 
  Portal inflammation                           0                         1                                                    3                                                                                                 3                                                                                                 
  Ballooning degeneration                       0                         1                                                    2                                                                                                 2                                                                                                 
  Fatty changes                                 0                         1                                                    1                                                                                                 2                                                                                                 
  Congestion of the sinusoids                   0                         1                                                    1                                                                                                 2                                                                                                 
  **Total grade**                               **0**                     **6**[\*](#tfn16-ijn-14-1919){ref-type="table-fn"}   **10**[Ŧ](#tfn16-ijn-14-1919){ref-type="table-fn"},[£](#tfn18-ijn-14-1919){ref-type="table-fn"}   **14**[Ŧ](#tfn16-ijn-14-1919){ref-type="table-fn"},[§](#tfn19-ijn-14-1919){ref-type="table-fn"}   

**Notes:** Data were expressed as mean ± SD.

*P*\<0.05, and

*P*\<0.001 as compared to the control group.

*P*\<0.05 as compared to the "Control +10 mg/kg NPs" group and

*P*\<0.05 as compared to the "Control +50 mg/kg NPs". The Ishak system was applied for scoring liver injury.[@b20-ijn-14-1919] The histopathological changes in intestine were evaluated according to the study by Erben et al.[@b32-ijn-14-1919]

[^1]: These authors contributed equally to this work
